| Value | ₹119.5 Cr |
|---|
NSE filing, NSE: ZOTA. Summary written from the filing by ALFA Finder's alert engine.
Zota Healthcare Ltd: key numbers
- Share price
- ₹1,217.10
- Market cap
- ₹4,215 Cr
- Revenue (annual)
- ₹538.7 Cr
- Net profit (annual)
- ₹-73.94 Cr
- P/E (TTM)
- -37.4×Sector 47.2×
- Promoter holding
- 49.38%+0.00% QoQ
- FII holding
- 6.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zota Healthcare Ltd
All →Zota Healthcare Earnings Call Transcript: Key Takeaways
Zota reported robust revenue growth driven by Dawaa India, though consolidated PAT remains in loss.
Zota Healthcare Results Update
Zota Health Care reported Q2FY27 consolidated revenue up 54.58% YoY and positive EBITDA of ₹791.72 lakhs. The Davaindia network reached 2,840 stores.
Zota Healthcare Q2 FY27 Results: Net Loss of ₹26 Cr, Loss Widens
Zota Healthcare Ltd reported revenue from operations of ₹199.3 Cr (+54.6% YoY) and a net loss of ₹26 Cr for Q2 FY27.
- Key figure
- Net loss ₹26 Cr
Zota Healthcare Board Meeting Date
Zota Health Care will hold a board meeting on October 28, 2026. The meeting will consider the company's half-yearly unaudited financial results.
Zota Healthcare Price Movement Clarification
Zota Health Care Limited clarified to the NSE that the recent increase in its share volume is market-driven, with no undisclosed material information or impending announcements.
Zota Healthcare Business Update
Zota Health Care updated its store count for Q2FY27, reporting 2,840 total stores as of September 30, 2026, after opening 20 new outlets during the quarter.
- store expansion
- 20.0 stores
Other merger & restructuring announcements
All →India Glycols Merger & Restructuring
India Glycols disclosed that IGL Spirits received BSE and NSE listing approval for 6.70 crore demerger shares. Trading in these equity shares begins on 4 November 2026.
Kaynes Technology India Merger & Restructuring Worth ₹0.25 Cr
Kaynes Technology will incorporate Kaynes Arabia Electronics Company in Saudi Arabia, holding 100% for electronics manufacturing for GCC markets. Cash consideration is Rs. 0.25 Crore, funded through multiple tranches.
- Value
- ₹0.25 Cr
RPSG Ventures Merger & Restructuring
RPSG Ventures' step-down subsidiary RPSG Brands Mena incorporated RPSG Foods & Health Products Trading FZE in Dubai's Jebel Ali Free Zone. The new entity has AED 50,000 share capital and is yet to commence business.
Rajasthan Securities Merger & Restructuring Worth ₹1 Cr
Rajasthan Securities' board approved incorporating a wholly owned subsidiary in India. Initial cash subscription of up to Rs 1 Crore is planned.
- Value
- ₹1.00 Cr
Amara Raja Energy & Mobility Merger & Restructuring Worth ₹100 Cr
Amara Raja board approved a wholly owned subsidiary, Amaron Assist, in Telangana. Initial investment of up to Rs. 100 crore is planned.
- Value
- ₹100.0 Cr
Sudarshan Chemical Industries Merger & Restructuring Worth ₹795.9 Cr
Sudarshan Chemical completed sale of VP4 Frankfurt GmbH to Celanese for about Rs 795.9 crore. VP4 Frankfurt is no longer a step-down subsidiary.
- Value
- ₹795.9 Cr